22 May 2013
Keywords: cozaar, license, application, uk, merck, sharpe, dohme
Article | 28 November 1994
- Merck Sharpe & Dohme has filed a license application in the UK for
Cozaar (losartan), its angiotensin II antagonist for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 November 1994
5 December 1994
21 May 2013
© 2013 thepharmaletter.com